Drug Delivery News

Impax Pharmaceuticals is paying AstraZeneca ($AZN) $130 million so it can license U.S. commercial rights for three versions of the migraine drug Zomig. Their agreement also allows for new variations Read more >>

Right now, protein biopharmaceuticals are fairly diluted and administered intravenously at a hospital. A group of researchers from The University of Texas at Austin promise to transform the nature of Read more >>

European regulators have slammed on the breaks and delayed an approval decision for Amsterdam Molecular Therapeutics' Glybera, a gene therapy delivered by an altered virus for patients with a rare Read more >>

Say hello to Bydureon, a once-weekly injectable treatment for Type 2 diabetes finally approved by the FDA on Jan. 27. Amylin Pharmaceuticals ($AMLN) developed the drug using controlled release drug Read more >>

For the second time this year, Durect ($DRRX) faces a setback over its controlled-release anti-pain drug Posidur. The Cupertino, CA-based company disclosed that its European development and marketing Read more >>

Scientists at Brigham and Women's Hospital in Boston and Boston University have concocted a new drug delivery mechanism that could work over a period of months, carrying a pain or cancer treatment. Read more >>

Scientists are eyeing nanotech drug delivery as a way to help reduce organ transplant failures. The Times of India reports that researchers at the University of Strathclyde in Scotland are working on Read more >>

Less than two years after paying $200 million for diabetes pump developer Medingo, Roche's diagnostic division ($RHHBY) is shutting down the company and transferring its operations from Israel to Read more >>

Nanotech-enabled medicines are coming of age. That's the big message I came away with after a recent telephone chat with Kevin Bitterman, a life sciences investor with Polaris Venture Partners in Read more >>

Another player is joining the field of nanomedicine-related research and development: The Arkansas Nanomedicine Center. To be housed at The University of Arkansas' College of Medicine, the new Read more >>

The FDA slammed Alexza Pharmaceuticals ($ALXA) with another setback this week in its drive to bring the antipsychotic drug Adasuve to market. Regulators are extending by three months their review of Read more >>

Global generic drug manufacturer Mylan ($MYL) has begun selling a version of the anti-epilepsy drug Levetiracetam for intravenous use in a variation intended to be safer and easy to use. Doses are Read more >>

Nanoparticles often deliver cancer drugs prematurely, releasing their cargo at the slightest trigger, missing their target. Researchers concocted a new version that appears able to last longer, Read more >>

Carticept Medical will launch its new ultrasound-guided, computer-controlled drug delivery system for joint pain medications sometime during its fiscal 2012 first quarter, fueled by a new, $10 Read more >>

Bioject Medical Technologies ($BJCT) has hired a financial adviser to explore the always-ominous "strategic alternatives." One option for the maker of needle-free drug delivery systems: selling the Read more >>